We’re thrilled to announce that Redpoint is co-leading Abridge’s $150M Series C. Abridge is the leading generative AI company for clinical documentation. Healthtech is a difficult space. There remains a large gap between the health system we want and what we have. Companies often face trade-offs between full impact and viable business models. Sales cycles are long. It’s often not clear just how helpful some technology really is.
Investing in Abridge
Investing in Abridge
Investing in Abridge
We’re thrilled to announce that Redpoint is co-leading Abridge’s $150M Series C. Abridge is the leading generative AI company for clinical documentation. Healthtech is a difficult space. There remains a large gap between the health system we want and what we have. Companies often face trade-offs between full impact and viable business models. Sales cycles are long. It’s often not clear just how helpful some technology really is.